FUTRUE GmbH Proposes Squeeze-Out for PharmaSGP Minority Shareholders

FUTRUE GmbH has announced its intention to initiate a squeeze-out of minority shareholders of PharmaSGP Holding SE. The company currently holds over 95% of PharmaSGP shares, as per German Stock Corporation law. This significant ownership gives FUTRUE the right to propose the acquisition of remaining shares against cash compensation.

The cash compensation offer will be disclosed following a thorough valuation of PharmaSGP. Upon finalizing the compensation, PharmaSGP will schedule an extraordinary general meeting to deliberate the share transfer resolution. This move follows FUTRUE's earlier declaration to delist PharmaSGP and seeks consolidation.

PharmaSGP Holding SE is recognized for its broad range of OTC pharmaceuticals focusing on natural active ingredients. With a strong market presence in Germany, they plan further growth across Europe, bolstered by strategic acquisitions.